Kenneth Rosenfield


|
|

Dr. Rosenfield is a Master of SCAI and Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. Dr. Rosenfield is a master clinician and interventionalist has dedicated much of his career to educating fellows, residents, students, and colleagues. He received the distinguished Laennec award for his outstanding teaching and mentorship. As a researcher and clinical trialist, he designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He served as President of SCAI and was President of the MA ACC, serving on the Board of Governors of ACC. Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, founder of the National PERT Consortium.

Optimizing PCI (O-PCI) is a series of educational meetings dedicated to helping cardiologists optimize decision-making in interventional cardiac procedures using state-of-the-art intravascular imaging and physiology technologies.

Our renowned international faculty is committed to helping cardiologists master the interpretation of invasive diagnostic devices and treat them with precision, thus improving optimal patient outcomes.